Palisade Bio (PALI) Interest Expenses (2010 - 2026)
Palisade Bio (PALI) posted quarterly Interest Expenses of $1000.0 for Q1 2026, little changed year-over-year from $1000.0 in Q1 2025, and down 80.0% quarter-over-quarter from $5000.0 in Q4 2025.
Palisade Bio (PALI) Interest Expenses (2010 - 2026) Analysis & Trends
Palisade Bio (PALI) has reported Interest Expenses for 17 consecutive years, with $1000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Expenses changed 0.0% year-over-year to $1000.0; the TTM figure through Mar 2026 stood at $13000.0 (down 7.14% YoY), while the FY2025 annual figure was $27.3 million, down 15.96% from the prior year.
- Interest Expenses slipped to $1000.0 in Q1 2026 per PALI's latest filing, from $5000.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $35.6 million in Q1 2023 and bottomed at $1000.0 in Q1 2025.
- Historically, Interest Expenses has averaged $2.1 million across 5 years, with a median of $6000.0 in 2024.
- Annual changes were most pronounced in 2023 — Interest Expenses soared 82793.02% — and 2024, when it sank 99.96%.
- Palisade Bio's Interest Expenses stood at $2000.0 in 2022, then surged by 100.0% to $4000.0 in 2023, then jumped by 50.0% to $6000.0 in 2024, then fell by 16.67% to $5000.0 in 2025, then tumbled by 80.0% to $1000.0 in 2026.
- Business Quant data shows PALI's Interest Expenses at $1000.0 in Q1 2026, $5000.0 in Q4 2025, and $5000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 439.40 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 52.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.70 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 39.74 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 335,572.77 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 218.10 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 82.05 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Palisade Bio | 372.94 Mn | 247.74 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,000.00 |
| Mar 31, 2026 | 1,000.00 |
| Dec 31, 2025 | 5,000.00 |
| Dec 31, 2025 | 5,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Jun 30, 2025 | 2,000.00 |
| Jun 30, 2025 | 2,000.00 |
| Mar 31, 2025 | 1,000.00 |
| Mar 31, 2025 | 1,000.00 |
| Dec 31, 2024 | 6,000.00 |
| Dec 31, 2024 | 6,000.00 |
| Sep 30, 2024 | 6,000.00 |
| Sep 30, 2024 | 6,000.00 |
| Jun 30, 2024 | 9,000.00 |
| Jun 30, 2024 | 9,000.00 |
| Mar 31, 2024 | 13,000.00 |
| Mar 31, 2024 | 13,000.00 |
| Dec 31, 2023 | 4,000.00 |
| Dec 31, 2023 | 4,000.00 |